A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01166971
Collaborator
(none)
65
3
2
21.7

Study Details

Study Description

Brief Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with the AcrySof® IQ ReSTOR® +3 versus those bilaterally implanted with the Tecnis Multifocal 1-piece.

Condition or Disease Intervention/Treatment Phase
  • Device: ReSTOR +3
  • Device: Tecnis MF
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
65 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs
Study Start Date :
Jul 1, 2010
Actual Primary Completion Date :
Mar 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: ReSTOR +3

Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction

Device: ReSTOR +3
Bilateral implantation of ReSTOR +3 Intraocular Lenses (IOLs) after cataract extraction

Active Comparator: Tecnis MF

Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction

Device: Tecnis MF
Bilateral implantation of Tecnis Multifocal (MF) Intraocular Lenses (IOLs) after cataract extraction

Outcome Measures

Primary Outcome Measures

  1. Defocus Curve [3 months after surgery]

    A defocus curve is created by multiple measurements of one's visual acuity at different spherical powers (recorded as Diopters (D)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution".

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosed with bilateral cataracts

  • candidate for presbyopic lens

Exclusion Criteria:
  • 1 Diopter (D) preoperative astigmatism by Keratometry (K)readings

  • pre-existing conditions that could skew the results

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Eye Center of North Florida Panama City Florida United States 32405
2 Carolina Eye Care Physicians Charleston South Carolina United States 29414
3 Whitsett Vision Group Houston Texas United States 77055

Sponsors and Collaborators

  • Alcon Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT01166971
Other Study ID Numbers:
  • M09-050
First Posted:
Jul 21, 2010
Last Update Posted:
Nov 24, 2011
Last Verified:
Nov 1, 2011
Keywords provided by Alcon Research
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Bilateral diagnosis of cataracts of subjects >21 years of age
Pre-assignment Detail During the preoperative exam, subjects were examined to ensure they met the inclusion/exclusion criteria.
Arm/Group Title ReSTOR +3 Tecnis MF
Arm/Group Description Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction
Period Title: Overall Study
STARTED 33 31
COMPLETED 32 30
NOT COMPLETED 1 1

Baseline Characteristics

Arm/Group Title ReSTOR +3 Tecnis MF Total
Arm/Group Description Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction Total of all reporting groups
Overall Participants 33 31 64
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
19
57.6%
10
32.3%
29
45.3%
>=65 years
14
42.4%
21
67.7%
35
54.7%
Sex: Female, Male (Count of Participants)
Female
18
54.5%
20
64.5%
38
59.4%
Male
15
45.5%
11
35.5%
26
40.6%

Outcome Measures

1. Primary Outcome
Title Defocus Curve
Description A defocus curve is created by multiple measurements of one's visual acuity at different spherical powers (recorded as Diopters (D)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution".
Time Frame 3 months after surgery

Outcome Measure Data

Analysis Population Description
In the ReSTOR +3 population, 1 subject did not complete the assessment at -5.00 D; therefore, only 32 subjects were used for this measure.
Arm/Group Title ReSTOR +3 Tecnis MF
Arm/Group Description Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction
Measure Participants 33 29
-5.00 Diopter (D)
0.585
(0.204)
0.653
(0.116)
-4.50 D
0.490
(0.204)
0.475
(0.115)
-4.00 D
0.388
(0.189)
0.337
(0.107)
-3.50 D
0.261
(0.183)
0.168
(0.114)
-3.00 D
0.126
(0.185)
0.046
(0.104)
-2.50 D
0.017
(0.144)
0.073
(0.113)
-2.00 D
0.055
(0.147)
0.222
(0.178)
-1.50 D
0.245
(0.175)
0.326
(0.120)
-1.00 D
0.212
(0.144)
0.225
(0.128)
-0.50 D
0.052
(0.132)
0.072
(0.120)
0.00 D
-0.048
(0.097)
-0.044
(0.085)
0.50 D
0.035
(0.112)
0.032
(0.111)
1.00 D
0.258
(0.140)
0.237
(0.200)
1.50 D
0.434
(0.153)
0.364
(0.176)
2.00 D
0.539
(0.168)
0.446
(0.136)

Adverse Events

Time Frame Adverse events were collected at all study visits.
Adverse Event Reporting Description
Arm/Group Title ReSTOR +3 Tecnis MF
Arm/Group Description Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction
All Cause Mortality
ReSTOR +3 Tecnis MF
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
ReSTOR +3 Tecnis MF
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/32 (0%) 0/30 (0%)
Other (Not Including Serious) Adverse Events
ReSTOR +3 Tecnis MF
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/32 (0%) 0/30 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

The existence of this clinical study is confidential and should not be discussed with persons outside of the study. You shall hold confidential, and not disclose directly or indirectly to any third party other than those persons involved in the study who have a need to know, the protocol, the data arising out of the study, and any other information related to the study or to Alcon's products or research programs that is provided by Alcon to you (the "Confidential Information").

Results Point of Contact

Name/Title Director of Alcon Clinical
Organization Alcon Research, Ltd.
Phone 888.451.3937; 817.568.6725
Email medinfo@alconlabs.com
Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT01166971
Other Study ID Numbers:
  • M09-050
First Posted:
Jul 21, 2010
Last Update Posted:
Nov 24, 2011
Last Verified:
Nov 1, 2011